Atlas Trials

The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis

Clinical trial NCT03141112 · UNKNOWN

Trial details

NCT number
NCT03141112
Sponsor
Radovan Uvizl
Status
UNKNOWN
Study type
OBSERVATIONAL
Severe Sepsis
Start date
2016-08-01
Primary completion
2018-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.